Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is set to report earnings Tuesday morning. While most analysts and investors have a bleak view of the company I am extremely bullish. I expect an earnings beat and the stock to trade sharply higher in the coming weeks. The reason for my optimism is based on the stock chart having broken out to the upside. This is a breakout that is now consolidating in a bullish manner and signals significant upside coming. Everything about the stock chart signals upside back above $20 per shares. Valeant Pharmaceuticals may soon be a darling of the stock market once more.